Medicine Information

Bextra Withdrawal Could Be Just the Beginning for Pfizer


The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Last year Merck sold about $2.5 billion worth of Vioxx, and Pfizer sold about $1.3 billion worth of Bextra. The profits are huge, but so are the losses if a problem should develop with a pharmaceutical product. Pfizer voluntarily withdrew the popular anti-inflammatory drug Bextra from the market last month, and their stock has suffered from both the loss of sales and the potential for a large number of product liability lawsuits. Pfizer may have to endure a double whammy this year as the FDA announced that they are investigating reports that the impotence drug Viagra may be linked to cases of blindness in male users. Cialis and Levitra were also mentioned in the report, although most of the cases involved the use of Viagra.

The FDA reports shouldn't cause alarm; the agency says that it is investigating fewer than 50 incidents of blindness in patients who use a drug that has been used by more than twenty million people since its introduction seven years ago. The FDA investigation says less about the likelihood of blindness in patients than it does about the agency's own concerns about its reputation. The FDA rightly insists upon rigorous testing of drugs before they reach the market in the name of public safety. But that coin has two sides, and there are those who say that the agency is too quick to approve potentially dangerous drugs and others who say that the agency's testing isn't thorough enough. Adding fuel to the fire are the recent memos obtained from Merck employees that suggest that the company was aggressively marketing Vioxx even though their sales staff knew the drug was potentially dangerous.

There may be no link between Viagra and blindness at all, as the form of sudden blindness alleged to have been caused by Viagra use is common to the sorts of patients who have erectile disfunction. The FDA is just being cautious, as they should be. Further tests will determine if there is an actual link. The party likely to suffer immediately is Pfizer, as stockholders, already concerned about Bextra lawsuits, drove the stock price lower immediately upon the release of the Viagra news. Sales will probably decrease, too, as patients who are now accustomed to reading about drugs being withdrawn from the market may shy away from the product until further tests are done. That could present a huge income for Pfizer, as they currently sell about $2 billion worth of Viagra each year. The drug business is a profitable one, but like any business, comes with risks. This year, it would seem that Pfizer is getting a double dose of bad medicine.

Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


HuffPost

With Culinary Medicine, Doctors Are Finally Learning About Food
HuffPost
Culinary medicine picks up where basic (and brief) med school nutrition education leaves off. It's nutrition with context. Immersive, holistic and food-focused, it takes place in the kitchen as well as the classroom, with med students working side by ...



Philly.com

Does using complementary medicine for cancer reduce patients' survival?
Philly.com
Yale School of Medicine researchers aimed to find out by analyzing a national cancer database. Their findings, published Thursday in JAMA Oncology, offered a troubling answer: complementary medicine users are more likely than non-users to refuse a ...
Cancer patients who choose complementary medicine are twice as likely to die within seven years, study suggestsTelegraph.co.uk
Complementary medicine for cancer can decrease survivalYale News
Complementary Medicine and Refusal of Conventional Cancer TxMedscape
Daily Mail -Healio
all 13 news articles »


Press Herald

Integrative Medicine Gives Providers More Paths to Wellness
Press Herald
If you've grown up with traditional Western medicine, you might be surprised to have a doctor ask you a question like “What's going on in your life?” or “What do you think is at the root of this health condition?” But that's how the conversation might ...



Telegraph.co.uk

We can treat Aids with medicine – but only love will beat its insidious ...
Telegraph.co.uk
Aids activism has always been about connecting with people on the margins. Our movement is defined by uplifting those cast aside by society: reaching out with ...

and more »


New York Times

Blood Pressure Medicine Is Recalled
New York Times
If the information is not there, patients should contact the pharmacy where they got it, the F.D.A. said. The agency also said that patients taking valsartan, or medicines that use it as an ingredient, should continue taking it until they have a ...
FDA issues recall on blood pressure medicinenbc25news.com
FDA announces voluntary recall of several medicines containing valsartan following detection of an impurityFDA.gov
Valsartan: MedlinePlus Drug InformationMedlinePlus
CNN -EPA -EPA
all 322 news articles »


AAFP News

Community Colleges Hold Key to Family Medicine Diversity
AAFP News
It's also no secret that family medicine owns a bigger chunk of the primary care pie than any other specialty. When combined, those factors provide an enticing backdrop for newly published research in which authors make the case for utilizing America's ...



Seven days in medicine: 11-17 July
The BMJ
Seven days in medicine: 11-17 July. BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3137 (Published 19 July 2018) Cite this as: BMJ 2018;362:k3137. Article; Related content; Metrics; Responses; Peer review. Loading ...



STAT

The medical community is changing its mind on chronic fatigue syndrome. Why aren't insurers?
STAT
According to a 2015 report 13 from the Institute of Medicine (now the National Academy of Medicine), it is an organic illness, often triggered by a viral infection, that involves immunological and neurological dysfunctions. People with it experience ...



International Atomic Energy Agency

IAEA Partners with Brazil's SBMN to Facilitate Training for Nuclear Medicine Professionals in Latin America, the ...
International Atomic Energy Agency
The IAEA signed a practical arrangement today with the Brazil-based Sociedade Brasileira de Medicina Nuclear (SBMN) which will increase training opportunities for nuclear medicine professionals in Latin America and the Caribbean (LAC), as well as in ...



EU and Japan reinforce their collaboration on inspections of medicine manufacturers
EU News
The scope of this agreement has now been extended to include sterile medicines, certain biological medicines including vaccines and immunologicals, and active pharmaceutical ingredients (APIs) of any medicine covered in the agreement. This means that ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006